摘要
目的 本文旨在探究长白山野生菌松黄、杨树黄、暴马子黄对对乙酰氨基酚(APAP)所致的小鼠肝损伤的保护作用及生物学特性;方法 通过对采集到的三种桑黄的文献及实物对照观察研究其生物学特性;采用APAP构建小鼠肝损伤模型,随机将84只雄性小鼠分成6组,每组均为14只,依次为正常对照(NC)组、肝损伤模型(LD)组、阳性对照(Sil+LD)组、松黄+LD组、杨黄+LD组、暴马子黄+LD组,其中松黄+LD组、杨黄+LD组、暴马子黄+LD组均以100 mg/kg分别灌胃给药,NC组和LD组则分别灌胃等量生理盐水,每天2次,连续给药7d后,记录给药前后体质量;计算肝脏指数;采用微板法检测小鼠血清中的ALT、AST和LDH生化指标,采用酶联免疫吸附测定(ELISA)法检测肝组织中TNF-α、IL-6 以及IL-1β炎症因子。结果 通过文献以及实物对比可知,三种黄分别为porus vaninii Sanghuang杨黄、Inonotus vaninii Sanghuang暴马子黄、porus baumii Sanghuang松黄,三者在地区分布、孔口的个数以及子实体形态上存在一些较为明显的特征差异;给药前后各组小鼠的体重均无明显差异(p>0.05);与LD组比较,松黄、杨树黄、暴马子黄混悬液可明显降低APAP诱导的ALT、AST和LDH水平(P<0.05),且可使脏器指数和肝组织中的TNF-α、IL-6 以及IL-1β的水平明显降低(p<0.001)。结论 长白山野生菌松黄、杨树黄、暴马子黄均属于桑黄类群种类,通过文献对比以及实物对照可进行区分;长白山野生菌种松黄、杨树黄、暴马子黄均可对APAP诱导的肝损伤起到保护的作用,其可能的机制为减少炎症反应。
关键词: 药物性肝损伤;松黄;杨树黄;暴马子黄;对乙酰氨基酚
Abstract
Objective This study aims to explore protective effect of APAP induced liver injury in mice and biological characteristics of wild fungi Phellinus vaninii Sanghuang、Inonotus vaninii Sanghuang、Phellinus baumii Sanghuang in Changbai Mountain. Methods The biological characteristics of three kinds of Phellinus linteuswere studied through literature and physical control observation; The mouse liver injury model of mice was construsted by APAP, and 84 male mice were randomly divided into 6 groups,14 mice for each group, followed by normal control group (NC),APAP liver injury model (LD) group, positive contrast (Sil + LD )group, the Phellinus vaninii Sanghuang + LD group, the Inonotus vaninii Sanghuang + LD group,and the Phellinu sbaumii Sanghuang + LD group. The Phellinus vaninii Sanghuang + LD group, the Inonotus vaninii Sanghuang + LD group, and the Phellinus baumii Sanghuang + LD group were intragastrically administered with 100 mg/kg, respectively, twice a day, After 7 consecutive days, Record weight before and after administration; calculate liver index; Detection of the biochemical indexes in serum of mice by microplate method, and detection of TNF-α、IL-6 and IL-1βin liver tissue by ELISA. Results Three kinds of yellows are Phellinus vaninii Sanghuang、Inonotus vaninii Sanghuang and Phellinus baumii Sanghuang, respectively. There are some obvious differences in regional distribution, number of orifices and morphology of sub-entities; There was no significant difference in the weight of mice in each group before and after administration (p > 0.05). Compared with LD group, The suspensions of Phellinus vaninii Sanghuang、Inonotus vaninii Sanghuang、Phellinus baumii Sanghuang could significantly reduce the ALT 、AST and LDH levels induced by APAP (P < 0.05 ),and significantly reduce the organ index and the levels of TNF-α、IL-6 and IL-1β in liver tissue ( p < 0.001 ). Conclusion wild fungi Phellinus vaninii Sanghuang、Inonotus vaninii Sanghuang、Phellinus baumii Sanghuang in Changbai Mountain belong to Phellinus linteus groups, which can be distinguished by literature comparison and physical control; They can protect liver injury induced by APAP, and the possible mechanism is to reduce inflammatory response.
Key words: Drug-induced liver injury; Phellinus vaninii Sanghuang; Inonotus vaninii Sanghuang; Phellinus baumii Sanghuang; Paracetamol
参考文献 References
[1] 陈建彤,卢露,金之怡,等.对乙酰氨基酚所致急性肝损伤防治的研究进展[J].温州医科大学学报,2021,51(07):593-599.
[2] Hui Ye,Leonard J Nelson,Manuel Gómez del Moral,et. Dissecting the molecular pathophysiology of drug-induced liver injury[J].World Journal of Gastroenterology, 2018,24(13): 1373-1385.
[3] 王立冬. 商陆皂苷甲防治对乙酰氨基酚诱导的急性肝损伤的作用及机制[D].吉林大学,2017.
[4] 李铮.白术挥发油对小鼠急性肝损伤的作用及其机制[D].吉林大学,2020.
[5] 杨虹,彭芳,刘刚,等.基于脂类代谢组学研究对乙酰氨基酚对小鼠药物性肝损伤的早期毒性[J].中国药房.2019,30(15): 2031-2036.
[6] Lancaster Elizabeth M,Hiatt Jonathan R,Zarrinpar Ali. Acetaminophen hepatotoxicity: an updated review.[J]. Archives of toxicology, 2015,89(2):193-199.
[7] 余朋飞,吴桥,段钟平,等.对乙酰氨基酚致药物性肝损伤的机制研究进展[J].临床肝胆病杂志,2019,35(09):2108-2112.
[8] 吴佳栩,江锋,薛婧.中医药治疗药物性肝损伤的现状与思考[J].中西医结合肝病杂志,2021,31(12):1119-1122.
[9] 吴声华,戴玉成.药用真菌桑黄的种类解析[J].菌物学报, 2020,39(05):781-794.
[10] 王豪,钱坤,司静,等.桑黄类真菌多糖研究进展[J].菌物学报,2021,40(04):895-911.
[11] 国微,邰志娟,刘凤霞,等.长白山区桑黄资源及其产业现状[J].农业与技术,2018,38(23):5-7.
[12] 安太成,杜利梅,王艳萍,等.山西中条山东段白桦树桑黄资源及其药用价值研究[J].安徽农业科学,2014,42(15):4621-4623
[13] 张洋洋,吕国英,方立林,等.桑黄主要活性物质的提取方法及药理活性研究进展[J].食药用菌,2021,29(05):404-408.
[14] 李小群,梁贵秋,刘开莉,等.桑黄活性成分的提取方法及应用研究进展[J].广西蚕业,2022,59(01):41-50.
[15] 荣丹,唐梦瑜,么越,等.桑黄活性物质提取分离及药理作用研究进展[J].中国食用菌,2022,41(06):1-6.
[16] 贺屏雅,杨玥,邸磊,等.不同基质栽培的药用鲍姆桑黄孔菌体外抗肿瘤活性的比较研究[J].菌物学报,2020,39(07): 1400 -1409.
[17] 吕辉.桑黄多糖及黄酮抗肿瘤活性比较研究[J].中医学报,2018,33(01):27-29.
[18] 袁满,付婷伟,徐晨,等.桑黄子实体多糖提取工艺优化及其抗氧化活性[J].食品工业,2021,42(11):103-108.
[19] 郭姗姗,Rausch WD.不同品种桑黄抗氧化和抗炎的药理作用比较[J].中国药物警戒,2017,14(07):394-398.
[20] 周洪英,孙波,王卓仁,等.桑黄类真菌抑菌活性研究[J].北方蚕业,2021,42(01):6-35.
[21] 杜明. 桑黄多糖的提取及其对小鼠急性酒精肝损伤的保护作用研究[D].西北农林科技大学,2010.
[22] 吴声华.珍贵药用菌“桑黄”物种正名[J].食药用菌, 2012, 20(03):177-179.
[23] 包玉龙.APAP诱导小鼠急性肝损伤中免疫细胞的动态变化[J].现代农业,2021(04):68-72.